|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 512.70 USD | +0.45% |
|
-1.12% | +5.22% |
| Market Cap | 21.99B 18.97B 17.84B 16.26B 30.57B 2,087B 30.73B 211B 82.1B 1,062B 82.56B 80.77B 3,520B | P/E 2026 * |
19.7x | P/E 2027 * | 17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 19.02B 16.4B 15.43B 14.06B 26.44B 1,805B 26.58B 182B 71B 918B 71.4B 69.85B 3,044B | EV / Sales 2026 * |
6.06x | EV / Sales 2027 * | 5.28x |
| Free-Float |
53.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : United Therapeutics Corporation
| 1 day | +0.45% | ||
| 1 week | -1.12% | ||
| Current month | +0.45% | ||
| 1 month | -0.97% | ||
| 3 months | -5.86% | ||
| 6 months | +1.75% | ||
| Current year | +5.22% |
| 1 week | 507.03 |  | 531.76 |
| 1 month | 490.8 | | 541.03 |
| Current year | 455.63 | | 609.35 |
| 1 year | 375.61 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 1996-06-25 | |
| President | 54 | 2016-06-25 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 2015-03-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 2001-12-31 |
| Chairman | 71 | 1996-06-25 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 2001-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/27/26 | Exercice | Chief Executive Officer | 28,500 | 0.0671% | ||
| 8/26/26 | Exercice | Chief Executive Officer | 28,500 | 0.0671% | ||
| 8/25/26 | Exercice | Chief Executive Officer | 28,500 | 0.0671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.45% | -1.12% | +68.23% | +124.82% | 21.89B | |
| +0.28% | -5.97% | +58.34% | +108.22% | 1,031B | |
| +2.01% | -0.71% | +53.07% | +68.99% | 641B | |
| +1.39% | -2.18% | +23.57% | +75.43% | 453B | |
| -1.50% | -7.04% | +33.55% | +33.94% | 349B | |
| +6.25% | +2.04% | +28.97% | +46.57% | 290B | |
| -0.07% | -4.12% | +0.95% | +11.79% | 252B | |
| +1.92% | -0.93% | +52.28% | +70.67% | 232B | |
| +0.51% | -4.52% | -19.50% | -54.83% | 201B | |
| +2.45% | +0.77% | +32.71% | +95.59% | 181B | |
| Average | +1.50% | -2.73% | +33.22% | +58.12% | 365.17B | |
| Weighted average by Cap. | +1.60% | -3.38% | +38.57% | +66.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.14B 2.71B 2.55B 2.32B 4.36B 298B 4.39B 30.12B 11.72B 152B 11.79B 11.53B 503B | 3.44B 2.97B 2.79B 2.54B 4.78B 327B 4.81B 33.01B 12.85B 166B 12.92B 12.64B 551B |
| Net income | 1.2B 1.03B 972M 885M 1.66B 114B 1.67B 11.49B 4.47B 57.81B 4.5B 4.4B 192B | 1.32B 1.14B 1.07B 974M 1.83B 125B 1.84B 12.64B 4.92B 63.61B 4.95B 4.84B 211B |
| Net Debt | -2.97B -2.56B -2.41B -2.2B -4.13B -282B -4.15B -28.51B -11.1B -144B -11.16B -10.92B -476B | -3.81B -3.28B -3.09B -2.81B -5.29B -361B -5.32B -36.51B -14.21B -184B -14.29B -13.98B -609B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | US$512.70 | +0.45% | 478,994 |
| 26-08-31 | US$510.38 | -0.99% | 538,523 |
| 26-08-28 | US$515.46 | -2.36% | 266,869 |
| 26-08-27 | US$527.91 | +2.17% | 391,005 |
| 26-08-26 | US$516.68 | -0.36% | 254,780 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
